173 related articles for article (PubMed ID: 28253273)
1. Elevated OPRD1 promoter methylation in Alzheimer's disease patients.
Ji H; Wang Y; Liu G; Chang L; Chen Z; Zhou D; Xu X; Cui W; Hong Q; Jiang L; Li J; Zhou X; Li Y; Guo Z; Zha Q; Niu Y; Weng Q; Duan S; Wang Q
PLoS One; 2017; 12(3):e0172335. PubMed ID: 28253273
[TBL] [Abstract][Full Text] [Related]
2. OPRK1 promoter hypermethylation increases the risk of Alzheimer's disease.
Ji H; Wang Y; Liu G; Xu X; Dai D; Chen Z; Zhou D; Zhou X; Han L; Li Y; Zhuo R; Hong Q; Jiang L; Zhang X; Liu Y; Xu L; Chang L; Li J; An P; Duan S; Wang Q
Neurosci Lett; 2015 Oct; 606():24-9. PubMed ID: 26300544
[TBL] [Abstract][Full Text] [Related]
3. Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease.
Chang L; Wang Y; Ji H; Dai D; Xu X; Jiang D; Hong Q; Ye H; Zhang X; Zhou X; Liu Y; Li J; Chen Z; Li Y; Zhou D; Zhuo R; Zhang Y; Yin H; Mao C; Duan S; Wang Q
PLoS One; 2014; 9(11):e110773. PubMed ID: 25364831
[TBL] [Abstract][Full Text] [Related]
4. Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
Xie B; Xu Y; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
J Alzheimers Dis; 2017; 56(1):391-401. PubMed ID: 27935556
[TBL] [Abstract][Full Text] [Related]
5. Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males.
Ji H; Wang Y; Jiang D; Liu G; Xu X; Dai D; Zhou X; Cui W; Li J; Chen Z; Li Y; Zhou D; Zha Q; Zhuo R; Jiang L; Liu Y; Shen L; Zhang B; Xu L; Hu H; Zhang Y; Yin H; Duan S; Wang Q
Mol Med Rep; 2016 Sep; 14(3):2732-8. PubMed ID: 27485706
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease.
Ozaki Y; Yoshino Y; Yamazaki K; Sao T; Mori Y; Ochi S; Yoshida T; Mori T; Iga JI; Ueno SI
J Psychiatr Res; 2017 Sep; 92():74-80. PubMed ID: 28412600
[TBL] [Abstract][Full Text] [Related]
7. Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease.
Xu C; Liu G; Ji H; Chen W; Dai D; Chen Z; Zhou D; Xu L; Hu H; Cui W; Chang L; Zha Q; Li L; Duan S; Wang Q
Mol Med Rep; 2018 Nov; 18(5):4297-4302. PubMed ID: 30152845
[TBL] [Abstract][Full Text] [Related]
8. Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
Li Y; Liu S; Wang H; Mai H; Yuan X; Li C; Chen X; Wen F
PLoS One; 2017; 12(3):e0173472. PubMed ID: 28278270
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: a matched case-control study.
Mao SQ; Sun JH; Gu TL; Zhu FB; Yin FY; Zhang LN
J Hum Hypertens; 2017 Aug; 31(8):530-536. PubMed ID: 28300071
[TBL] [Abstract][Full Text] [Related]
10. Association of AGTR1 Promoter Methylation Levels with Essential Hypertension Risk: A Matched Case-Control Study.
Fan R; Mao S; Zhong F; Gong M; Yin F; Hao L; Zhang L
Cytogenet Genome Res; 2015; 147(2-3):95-102. PubMed ID: 26658476
[TBL] [Abstract][Full Text] [Related]
11. Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer's disease patients.
Grosser C; Neumann L; Horsthemke B; Zeschnigk M; van de Nes J
Neurosci Lett; 2014 Apr; 566():241-6. PubMed ID: 24602981
[TBL] [Abstract][Full Text] [Related]
12. CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer's disease.
Mendioroz M; Celarain N; Altuna M; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Rubio I; Larumbe R; Erro ME; Méndez I; Echávarri C
Alzheimers Res Ther; 2016 Apr; 8(1):15. PubMed ID: 27094739
[TBL] [Abstract][Full Text] [Related]
13. Non-random distribution of methyl-CpG sites and non-CpG methylation in the human rDNA promoter identified by next generation bisulfite sequencing.
Pietrzak M; Rempala GA; Nelson PT; Hetman M
Gene; 2016 Jul; 585(1):35-43. PubMed ID: 27008990
[TBL] [Abstract][Full Text] [Related]
14. CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer's disease patients.
Silva PN; Furuya TK; Sampaio Braga I; Rasmussen LT; de Labio RW; Bertolucci PH; Chen ES; Turecki G; Mechawar N; Payão SL; Mill J; Smith MC
J Alzheimers Dis; 2013; 33(2):349-55. PubMed ID: 22954668
[TBL] [Abstract][Full Text] [Related]
15. OPRD1 Genetic Variation and Human Disease.
Crist RC; Clarke TK
Handb Exp Pharmacol; 2018; 247():131-145. PubMed ID: 28035534
[TBL] [Abstract][Full Text] [Related]
16. Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region.
Zhang H; Gelernter J; Gruen JR; Kranzler HR; Herman AI; Simen AA
J Hum Genet; 2010 May; 55(5):278-84. PubMed ID: 20300121
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Regulation of BMAL1 with Sleep Disturbances and Alzheimer's Disease.
Hulme B; Didikoglu A; Bradburn S; Robinson A; Canal M; Payton A; Pendleton N; Murgatroyd C
J Alzheimers Dis; 2020; 77(4):1783-1792. PubMed ID: 32925059
[TBL] [Abstract][Full Text] [Related]
18. Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease.
Ferri E; Arosio B; D'Addario C; Galimberti D; Gussago C; Pucci M; Casati M; Fenoglio C; Abbate C; Rossi PD; Scarpini E; Maccarrone M; Mari D
J Neurol Sci; 2016 Mar; 362():283-6. PubMed ID: 26944164
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of the GCK gene body is associated with the risk of essential hypertension.
Fan R; Wang WJ; Zhong QL; Duan SW; Xu XT; Hao LM; Zhao J; Zhang LN
Mol Med Rep; 2015 Aug; 12(2):2390-4. PubMed ID: 25892191
[TBL] [Abstract][Full Text] [Related]
20. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.
Carboni L; Lattanzio F; Candeletti S; Porcellini E; Raschi E; Licastro F; Romualdi P
Neurosci Lett; 2015 Sep; 605():44-8. PubMed ID: 26275347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
